期刊文献+

中西医结合治疗急性脑梗死50例疗效观察

Clinical Observation of Integrated Traditional Chinese and Western Medicine Therapy on Acute Cerebral Infarction,A Report of 50 Cases
下载PDF
导出
摘要 目的:观察中西医结合治疗急性脑梗死的疗效。方法:110例确诊病例随机分为治疗组50例,给予自拟参蛭黄汤加奥扎格雷纳注射液配合治疗;对照组60例采用奥扎格雷纳注射液治疗。结果:治疗28天,治疗组基本痊愈6例,显著进步18例,进步17例,无变化4例,恶化1例,总有效率86%;对照组基本痊愈3例,显著进步14例,进步26例,无变化14例,恶化2例,死亡1例,总有效率71.7%。两组比较有显著差异(P<0.05)。结论:治疗组总有效率和对高敏C-反应蛋白(hs-CRP)、载体脂蛋白(Apo-CⅢ)的抑制作用明显高于对照组。 Objective: To observe the curative effect of therapy of integrated traditional Chinese and western medicine on acute cerebral infarction. Method: 110 diagnosed cases were divided into two groups randomly. 50 cases in treatment group were treated by Shen -zhi -huang Decoction combined with sodium ozagrel. 60 cases in control group were treated only by sodium ozagrel. Result: After 28 days, in treatment group 6 cases were recovered, 18 cases were excellent, 17 cases were effective, 4 cases were unchanged, and 1 case was deteriorated. The total effective rate was 82%. In control group 3 cases were recovered, 14 cases were excellent, 26 cases were effective, 14 cases were unchanged, 2 cases were deteriorated, and 1 case was dead. The total effective rate was 72%. There was significant difference between the two groups (P 〈 0. 05 ). Conclusion : The total effective rate is higher in treatment group than that in control group. And hs - CRP and Apo - CⅢ are inhibited more markedly in treatment group than those in control group.
出处 《山西中医》 2009年第9期24-26,共3页 Shanxi Journal of Traditional Chinese Medicine
基金 河北省中医药管理局2008年度科研计划指导课题(编号2008139)
关键词 急性脑梗死 自拟参蛭黄方 hs—CRP Apo—CⅢ 奥扎格雷纳 中西医结合疗法 acute cerebral infarction, Shen - zhi - huang Decoction, hs - CRP, Apo - C Ⅲ, sodium oza- grel, integrated traditional Chinese and western medicine therapy
  • 相关文献

参考文献6

二级参考文献45

  • 1高晓兰 胡长梅 等.脑卒中临床数据库资料对比分析[J].中华神经科杂志,1999,32:160-160.
  • 2Lauer S, Walker D, Elshourbagy NA, et al. Two copies of the human apolipoprotein CⅠ gene are linked closely to the apolipoprotein E gene. J Biol Chem, 1988, 263: 7 277-286
  • 3Allan CM, Walker D, Segrest JP, et al. Identification and characterization of a new human gene (APOC4) in the apolipoprotein E, CⅠ, and C gene locus. Genomics, 1995, 28: 291-300
  • 4Allan CM, Walker D, Taylor JM. Evolutionary duplication of a hepatic control region in the human apolipoprotein E locus. J Biol Chem, 1995, 270: 26 278-281
  • 5Le Beyec J, Chauffeton V, Kan HY, et al. The -700/-310 fragment of the apolipoprotein AⅣ gene combined with the -890/-500 apolipoprotein CⅢ enhancer is sufficient to direct a pattern of gene expression similar to that for the ednogenous apolipoprotein AⅣ gene. J Biol Chem, 1999, 274 (8): 4 954-961
  • 6Ribalta J, Girona J, Vallve JC, et al. Vitamin A is linked to the expression of the AI-CⅢ-AⅣ gene cluster in familial combined hyperlipidemia. J Lipid Res, 1999, 40(3): 426-431
  • 7Schuller E, Patel N, Item C, et al. The genetic background modifies the effects of the obesity mutation, 'fatty', on apolipoprotein gene regulation in rat liver. Int J Obes Relat Metab Disord, 2000, 24(4): 460-467
  • 8Zhang L-H, Kotite L, Havel RJ. Identification, characterization, cloning and expression of apolipoprotein CⅣ, a novel sialoglycoprotein of rabbit plasma lipoproteins. J Biol Chem, 1996, 271: 1 776-783
  • 9Jong MC, Hofker MH, Havekes LM. Role of apo Cs in lipoprotein metabolism: Functional differences between apoC1, apoC2, and apoC3. Arterioscler Thromb Vasc Biol, 1999, 19: 472-484
  • 10Yamamoto M, Katoh N, Oilawa S. Evaluation of serum apolipoprotein CⅢ concentration by enzyme-linked immunosorbent assay and its higher concentration in cowa during midlactation then during the nonlactating stage. Am J Vet Res, 1998, 59 (11): 1 358-363

共引文献33111

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部